logo (3).png
Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC
September 27, 2018 07:00 ET | Midatech Pharma Plc
27 September 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC Total...
logo (3).png
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology
August 31, 2018 07:00 ET | Midatech Pharma Plc
­­31 August 2018 Midatech Pharma PLC("Midatech" or the "Company") Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™...
logo (3).png
Midatech Pharma PLC: Trading Update
July 25, 2018 07:00 ET | Midatech Pharma Plc
 25 July 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Trading Update Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on...
logo (3).png
Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal® to the Oncology Market in United States
July 23, 2018 07:11 ET | Midatech Pharma Plc
23 July 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal®...
logo (3).png
Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant
June 08, 2018 02:00 ET | Midatech Pharma Plc
8 June 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first patient in Gelclair® trial in stem cell transplant Patients now being enrolled at the...
Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer
May 25, 2018 07:00 ET | Midatech Pharma Plc
25 May 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer Midatech Pharma (AIM:...
Midatech announces changes in Senior Management Team
March 15, 2018 08:01 ET | Midatech Pharma PLC
15 March 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech announces changes in Senior Management Team Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty...
Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency
February 28, 2018 07:00 ET | Midatech Pharma PLC
28 February 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Midatech (AIM: MTPH, Nasdaq: MTP),...
Midatech Pharma Plc: Trading update
February 14, 2018 07:00 ET | Midatech Pharma PLC
  14 February 2018Midatech Pharma PLC("Midatech", "Company" or "Group") Trading update Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company...
Midatech and UCSF receive IND approval for DIPG treatment MTX110
January 16, 2018 07:01 ET | Midatech Pharma PLC
16 January 2018 Midatech Pharma PLC("Midatech", "Company" or "Group") Midatech and UCSF receive IND approval for DIPG treatment MTX110 - First treatment in patients in US expected as...